Sushrut S. Waikar MD
Section Chief, Nephrology
Norman G. Levinsky Professor, Nephrology
650 Albany St | (617) 638-7330swaikar@bu.edu
Sections
Nephrology
Biography
Sushrut S. Waikar, MD, MPH received a BA in English and Neuroscience at Amherst College, his MD at Yale, and an MPH at Harvard. He is the Norman G. Levinsky Professor of Medicine at Chobanian and Avedisian School of Medicine and Chief of Nephrology at Boston Medical Center. Dr. Waikar's research interests and active projects include epidemiologic, translational, and interventional studies to address novel and clinically important questions in nephrology. Current areas of investigation include optimal diagnostic testing in acute kidney injury and chronic kidney disease; biomarkers of kidney pathology and kidney fibrosis; the identification of relevant targets for interventional trials in kidney disease; and randomized controlled trials. He is a Principal Investigator of several NIH grants including the Kidney Precision Medicine Project (U01 DK133092), Multi-omics and Chronic Kidney Disease: Correlation with Histology (R01 DK108803), Discovery Science Collaborative for CKDu (U01 DK130060), NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial (U01AG076789) andThe Boston University Kidney and Medical Engineering Program (BU-KIDMEP, R25 DK128858).
Other Positions
Education
MD, Yale University
MPH, Harvard School of Public Health
English/Neuroscience/Neurology, BA, Amherst College
Publications
Mc Causland FR, Waikar SS, Claggett B, McMahon GM, Neto OMV, Rastogi A, Praditpornsilpa K, Correa-Rotter R, Kher V, Del Vecchio L, Solomon SD, Singh AK. Association of Different Definitions of Erythropoiesis-Stimulating Agent Hyporesponsiveness with Major Adverse Cardiovascular Events: Insights From ASCEND-D. Kidney360. 2025 May 07. PMID: 40333020.
Published on 5/6/2025Solomon M, Heydarpour M, Tsai LC, Honzel B, Brown J, Newman AJ, Parisien-LaSalle S, Wang TJ, Wei J, Zhang J, Waikar S, Vaidya A. The Impact Of Modern Industrialized Dietary Sodium Intake On The Plasma Proteome. Am J Hypertens. 2025 May 06. PMID: 40327765.
Published on 5/2/2025Claudel SE, Waikar SS, Verma A. Albuminuria References Ranges in Healthy US Adults. J Appl Lab Med. 2025 May 02; 10(3):767-771. PMID: 39981782.
Published on 4/1/2025Claudel SE, Schmidt IM, Waikar SS, Verma A. Albuminuria: A Marker of Adverse Kidney Outcomes in Heart Failure. J Am Coll Cardiol. 2025 Apr 01; 85(12):1372-1375. PMID: 40139894.
Published on 3/25/2025Menon R, Kimmel PL, Otto EA, Subramanian L, Berthier CC, O' Connor CL, Godfrey B, Naik AS, Sarwal M, Woodle ES, Pyle L, Choi YJ, Ladd P, Sedor JR, Rosas SE, Waikar SS, Bitzer M, Bjornstad P, Hodgin JB, Kretzler M. Not all controls are made equal: Definition of human kidney reference samples by single cell gene expression profiles. medRxiv. 2025 Mar 25. PMID: 40166576.
Published on 3/17/2025Schmidt IM, Verma A, Claudel SE, Palsson R, Srivastava A, Stillman IE, Beck LH, Waikar SS. Genetic Testing in Biopsy-Confirmed Kidney Disease. Kidney Med. 2025 May; 7(5):100994. PMID: 40321977.
Published on 2/11/2025Claudel SE, Schmidt IM, Waikar SS, Verma A. Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic (CKM) Syndrome. J Am Soc Nephrol. 2025 Feb 11. PMID: 39932805.
Published on 1/21/2025Kim T, Surapaneni AL, Leo H, Fino NF, Inker LA, Levey AS, Schmidt IM, Waikar SS, Coresh J, Grams ME, Rhee EP. Renal Arteriovenous Gradients for Greater Than 10,000 Circulating Proteins. Am J Kidney Dis. 2025 May; 85(5):659-662. PMID: 39848531.
Published on 1/16/2025Greenberg JH, Abraham AG, Xu Y, Schelling JR, Coca SG, Schrauben SJ, Wilson FP, Waikar SS, Vasan RS, Gutierrez OM, Shlipak MG, Ix JH, Warady BA, Kimmel PL, Bonventre JV, Parikh CR, Denburg M, Furth S. Biomarker Panels for Discriminating Risk of CKD Progression in Children. J Am Soc Nephrol. 2025 Jan 16. PMID: 39820177.
Published on 1/4/2025Waikar SS, Mogg R, Baker AF, Frendl G, Topper M, Adler S, Sultana S, Zhao R, King NMP, Piccoli SP, Sauer JM, Hoffmann S, Nunes I, Sistare FD. Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury. Clin Pharmacol Ther. 2025 May; 117(5):1272-1283. PMID: 39754474.
Media Mentions
Published on 7/9/2024
UACR Variability in Type 2 Diabetes Warrants Repeat Testing
Published on 4/7/2023
Kidney biopsy findings predict risk of cardiovascular events in CKD
Published on 3/23/2023
Kidney Biopsy Findings Predict Risk for Cardiovascular Events in CKD
Published on 3/20/2023
Kidney Biopsy Findings Predict Risk of Cardiovascular Events in CKD
Published on 4/15/2021
Existing Race-Based Predictions Can Perpetuate Racism in Nephrology
Published on 8/25/2020
Interpretation of urine sediment tests varies among nephrologists
View full list of 6 media mentions.